Brii Biosciences is a clinical-stage biotechnology company that focuses on developing innovative therapies for infectious diseases. The company was founded in 2018 by a team of experienced biotech executives and investors. Brii Biosciences is headquartered in Beijing, China, and has operations in the United States. The company's mission is to address the global health challenges posed by infectious diseases by developing new treatments and vaccines. Brii Biosciences is committed to working with partners around the world to accelerate the development of new therapies for infectious diseases.